Seaport Therapeutics, Inc. (SPTX) stock
SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.32+0.01 (+0.05%)
Close on Nov 19, 2026Market cap $980.68MP/E –Yield –
Seaport Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$22.68M | – |
| Q2 FY2026 | Jun 30, 2026 | -$26.14M | – |
| Q1 FY2026 | Mar 31, 2026 | -$20.17M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.77M | – |
| Q2 FY2025 | Jun 30, 2025 | -$15.59M | – |
| Q1 FY2025 | Mar 31, 2025 | -$20.26M | – |
See a number that looks wrong?